![]() ![]() The agreement allows Ionis ( IONS) to receive up to $3.6B in milestone and other payments in addition to tiered royalties in the range of low double-digit to mid-20s percentages. ![]() Premium virus protection and spam filter Sync data across mobile devices in real-time State and local taxes will apply. The partnership to develop and commercialize eplontersen in the U.S. IONOS email plans at a glance Host your business email with the experts. ![]() Business Email Hosting with rich webmail client, POP/IMAP access. Per the revised agreement, the British drugmaker has bought exclusive rights to commercialize eplontersen in Latin America in exchange for a $20M payment. Find top-ranking IONOS 1&1 Email & Office alternatives and competitors. Ionis Pharmaceuticals ( NASDAQ: IONS) announced Friday that AstraZeneca ( NASDAQ: AZN) has agreed to broaden its agreement for the company’s investigational therapy eplontersen to include countries in Latin America.Įplontersen, discovered by Ionis ( IONS) as a self-administered subcutaneous injection, is currently under FDA review for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) with a target action date of December 22, 2023.įollowing a 2021 agreement with the Carlsbad, California-based biotech, AstraZeneca ( AZN) obtained exclusive rights to commercialize eplontersen outside the U.S., except in certain countries in Latin America. login to access your ionos e-mail account and read your e-mail online with ionos webmail. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |